Bioventus Inc.
USD9.78
+0.00 (+0.00%)
CEO
Robert Claypoole
IPO Date
2021-02-11
Sector
Healthcare
Industry
Medical - Devices
Exchange
NASDAQ
Country
US
Open
$9.73
Prev. Close
$9.78
Day Low
$9.45
Day High
$9.90
52W Low
$5.81
52W High
$11.25
Market Cap
$0.66B
Volume
0.57M
| -20.5 |
| 31 Dec 2023 | FY | 64.1% | -30.5% | -90.0% | -19.3% | 2.27 | 1.53 | -2.1 |
| 31 Dec 2022 | FY | 64.6% | -31.0% | -48.8% | -11.6% | 1.29 | 0.90 | -1.0 |
| 31 Dec 2021 | FY | 70.3% | 4.5% | 4.2% | 1.6% | 0.78 | 1.45 | 34.0 |
| 31 Dec 2020 | FY | 72.7% | 5.1% | 11.5% | 3.3% | 1.32 | 1.73 | 44.1 |
| 31 Dec 2019 | FY | 73.3% | 2.0% | 4.8% | 1.5% | 1.38 | 2.06 | 159.3 |
| 31 Dec 2018 | FY | 73.6% | -3.8% | -8.4% | -2.8% | 1.34 | 2.27 | -89.4 |
| 31 Dec 2017 | FY | 68.5% | -0.6% | 0.0% | 0.0% | 0.00 | 0.00 | -666.0 |
| 31 Dec 2016 | FY | 66.7% | -6.5% | 0.0% | 0.0% | 0.00 | 0.00 | -60.8 |
| 8.4 |
| 27 Sept 2025 | Q3 | 67.0% | 2.3% | 1.9% | 0.4% | 1.94 | 1.74 | 35.3 |
| 28 Jun 2025 | Q2 | 68.2% | 5.1% | 4.6% | 1.1% | 2.12 | 1.48 | 15.1 |
| 29 Mar 2025 | Q1 | 65.8% | -2.1% | -1.8% | -0.4% | 2.34 | 1.43 | -56.5 |
| 31 Dec 2024 | Q4 | 66.8% | -0.1% | -0.1% | -0.0% | 2.27 | 1.31 | -1101.4 |
| 28 Sept 2024 | Q3 | 67.3% | -3.5% | -3.2% | -0.6% | 2.58 | 1.41 | -39.4 |
| 29 Jun 2024 | Q2 | 68.5% | -17.0% | -17.0% | -3.2% | 2.54 | 1.33 | -3.6 |
| 30 Mar 2024 | Q1 | 68.3% | -3.8% | -2.9% | -0.6% | 2.28 | 1.53 | -16.8 |
| 31 Dec 2023 | Q4 | 63.7% | -4.5% | -3.5% | -0.8% | 2.27 | 1.53 | -13.6 |